Treatment of relapsed and refractory myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of relapsed and refractory myeloma

Published:2008-01 Issue:8 Volume:49 Page:1470-1485
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Reece Donna E.,Leitch Heather A.,Atkins Harold,Voralia Michael,Canning Leah A.,LeBlanc Richard,Belch Andrew R.,White Darrell,Kovacs Michael J.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190802064941

Reference132 articles.

1. Canadian Cancer Society/National Cancer Institute of Canada: Canadian Cancer Statistics 2007. 2007, Toronto, Canada

2. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

3. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

4. Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients

5. Maintenance therapy with thalidomide improves survival in patients with multiple myeloma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Sociodemographic Characteristics of Patients With Relapsed and/or Refractory Multiple Myeloma and Their influence on Treatment in the Real-World Setting in Spain: The CharisMMa Study;Clinical Lymphoma Myeloma and Leukemia;2021-10

2. Multidrug resistance 1 (MDR1/ABCB1) gene polymorphism (rs1045642 C > T) and susceptibility to multiple myeloma: a systematic review and meta-analysis;Hematology;2018-03-01

3. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells;Leukemia Research;2015-04

4. Second autologous transplant as salvage therapy in multiple myeloma;British Journal of Haematology;2013-09-24

5. Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents;Leukemia & Lymphoma;2013-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3